[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …

The major goal for prostate cancer imaging in the next decade is more accurate disease
characterization through the synthesis of anatomic, functional, and molecular imaging …

The aim of this study was to compare the detection of bone metastases by 99mTc-methylene
diphosphonate (99mTc-MDP) planar bone scintigraphy (BS), SPECT, 18F-Fluoride PET …

Positron emission tomography (PET) is a radiotracer imaging method that yields quantitative
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …

Prostate cancer is biologically and clinically a heterogeneous disease that makes imaging
evaluation challenging. The role of imaging in prostate cancer should include diagnosis …

Detection of bone involvement is essential for optimal therapy of oncologic patients. The
purpose of imaging is to identify early bone involvement, to determine the full extent of the …

Purpose An increase of the serum PSA-level is a sensitive in vitro marker for recurrent
prostate cancer. However, it remains difficult to differentiate between local, regional or …

Purpose To prospectively evaluate the potential value of fluorocholine (FCH) positron
emission tomography (PET)/computed tomography (CT) in the preoperative staging of …

Prostate cancer, renal cancer, bladder, and other urothelial malignancies make up the
common tumors of the male genitourinary tract. For prostate cancer, common clinical …

OBJECTIVE. Prostate cancer is the most common noncutaneous malignancy among men in
the Western world. Imaging has recently become more important in the diagnosis, local …